Fate Therapeutics, Inc. (FATE)
1.46
+0.06
(+4.29%)
USD |
NASDAQ |
Feb 20, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 20:00
Fate Therapeutics Profit Margin (Quarterly) : -1.85K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| MannKind Corp. | 9.72% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
| Ardelyx, Inc. | -0.32% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -53.28% |
| Return on Assets | -38.08% |
| Return on Invested Capital | -41.23% |
| Gross Profit Margin (Quarterly) | -85.35% |
| Operating Margin (Quarterly) | -2.00K% |
| Return on Net Operating Assets | -134.9% |